{"id":"https://openalex.org/W2593445744","doi":"https://doi.org/10.1182/blood.v104.11.886.886","title":"All-trans-Retinoic acid (ATRA) and Arsenic Trioxide-Induced Expression and Regulation of Programmed Cell Death 4 (PDCD4) in Acute Promyelocytic Leukemia.","display_name":"All-trans-Retinoic acid (ATRA) and Arsenic Trioxide-Induced Expression and Regulation of Programmed Cell Death 4 (PDCD4) in Acute Promyelocytic Leukemia.","publication_year":2004,"publication_date":"2004-11-16","ids":{"openalex":"https://openalex.org/W2593445744","doi":"https://doi.org/10.1182/blood.v104.11.886.886","mag":"2593445744"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v104.11.886.886","doi":"https://doi.org/10.1182/blood.v104.11.886.886","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v104.11.886.886","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040193650","display_name":"B\u00fclent \u00d6zpolat","orcid":"https://orcid.org/0000-0001-8602-7463","observed_orcids":["https://orcid.org/0000-0001-8602-7463"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bulent Ozpolat","raw_affiliation_strings":["(Intr. by Kapil Mehta) 1Experimental Therapeutics, University of Texas-MD Anderson Cancer Center, Houston, TX, USA ; 2Experimental Therapeutics, University of Texas-MD Anderson Cancer Center, Houston, TX, USA ; 3Gene Regulation Section,Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD, USA and 4Experimental Therapeutics, University of Texas-MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"(Intr. by Kapil Mehta) 1Experimental Therapeutics, University of Texas-MD Anderson Cancer Center, Houston, TX, USA ; 2Experimental Therapeutics, University of Texas-MD Anderson Cancer Center, Houston, TX, USA ; 3Gene Regulation Section,Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD, USA and 4Experimental Therapeutics, University of Texas-MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031134829","display_name":"Maribel T\u00edrado-G\u00f3mez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maribel Tirado-Gomez","raw_affiliation_strings":["(Intr. by Kapil Mehta) 1Experimental Therapeutics, University of Texas-MD Anderson Cancer Center, Houston, TX, USA ; 2Experimental Therapeutics, University of Texas-MD Anderson Cancer Center, Houston, TX, USA ; 3Gene Regulation Section,Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD, USA and 4Experimental Therapeutics, University of Texas-MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"(Intr. by Kapil Mehta) 1Experimental Therapeutics, University of Texas-MD Anderson Cancer Center, Houston, TX, USA ; 2Experimental Therapeutics, University of Texas-MD Anderson Cancer Center, Houston, TX, USA ; 3Gene Regulation Section,Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD, USA and 4Experimental Therapeutics, University of Texas-MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048962207","display_name":"Nancy H. Colburn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nancy H. Colburn","raw_affiliation_strings":["(Intr. by Kapil Mehta) 1Experimental Therapeutics, University of Texas-MD Anderson Cancer Center, Houston, TX, USA ; 2Experimental Therapeutics, University of Texas-MD Anderson Cancer Center, Houston, TX, USA ; 3Gene Regulation Section,Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD, USA and 4Experimental Therapeutics, University of Texas-MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"(Intr. by Kapil Mehta) 1Experimental Therapeutics, University of Texas-MD Anderson Cancer Center, Houston, TX, USA ; 2Experimental Therapeutics, University of Texas-MD Anderson Cancer Center, Houston, TX, USA ; 3Gene Regulation Section,Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD, USA and 4Experimental Therapeutics, University of Texas-MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023542865","display_name":"Gabriel Lopez\u2010Berestein","orcid":"https://orcid.org/0000-0002-0366-0720","observed_orcids":["https://orcid.org/0000-0002-0366-0720"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gabriel Lopez-Berestein","raw_affiliation_strings":["(Intr. by Kapil Mehta) 1Experimental Therapeutics, University of Texas-MD Anderson Cancer Center, Houston, TX, USA ; 2Experimental Therapeutics, University of Texas-MD Anderson Cancer Center, Houston, TX, USA ; 3Gene Regulation Section,Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD, USA and 4Experimental Therapeutics, University of Texas-MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"(Intr. by Kapil Mehta) 1Experimental Therapeutics, University of Texas-MD Anderson Cancer Center, Houston, TX, USA ; 2Experimental Therapeutics, University of Texas-MD Anderson Cancer Center, Houston, TX, USA ; 3Gene Regulation Section,Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD, USA and 4Experimental Therapeutics, University of Texas-MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.25626589,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"104","issue":"11","first_page":"886","last_page":"886"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/promyelocytic-leukemia","display_name":"promyelocytic leukemia","score":0.8989999890327454},{"id":"https://openalex.org/keywords/all-trans-retinoic-acid","display_name":"all-trans retinoic acid","score":0.8970000147819519},{"id":"https://openalex.org/keywords/arsenic-trioxide","display_name":"arsenic trioxide","score":1.0},{"id":"https://openalex.org/keywords/pdcd4","display_name":"PDCD4","score":0.9369999766349792},{"id":"https://openalex.org/keywords/translational-suppression","display_name":"translational suppression","score":0.8550000190734863},{"id":"https://openalex.org/keywords/cap-dependent-translation","display_name":"cap-dependent translation","score":0.8700000047683716},{"id":"https://openalex.org/keywords/nb4-cells","display_name":"NB4 cells","score":0.7160000205039978},{"id":"https://openalex.org/keywords/atra-resistance","display_name":"ATRA resistance","score":0.6140000224113464},{"id":"https://openalex.org/keywords/pml-raralpha","display_name":"PML-RAR\u03b1","score":0.7440000176429749},{"id":"https://openalex.org/keywords/cell-differentiation","display_name":"cell differentiation","score":0.42399999499320984},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.5389999747276306},{"id":"https://openalex.org/keywords/post-transcriptional-regulation","display_name":"post-transcriptional regulation","score":0.6269999742507935}],"concepts":[{"id":"https://openalex.org/C2780386689","wikidata":"https://www.wikidata.org/wiki/Q7739","display_name":"Arsenic trioxide","level":3,"score":0.8803062438964844},{"id":"https://openalex.org/C2776601000","wikidata":"https://www.wikidata.org/wiki/Q612108","display_name":"Acute promyelocytic leukemia","level":4,"score":0.864118218421936},{"id":"https://openalex.org/C2781121885","wikidata":"https://www.wikidata.org/wiki/Q425517","display_name":"Retinoic acid","level":3,"score":0.5648356080055237},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5525215268135071},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.5161710381507874},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.5003924369812012},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.49857330322265625},{"id":"https://openalex.org/C2779963572","wikidata":"https://www.wikidata.org/wiki/Q29417","display_name":"Tretinoin","level":4,"score":0.4937184751033783},{"id":"https://openalex.org/C2776054693","wikidata":"https://www.wikidata.org/wiki/Q5323186","display_name":"EIF4G","level":5,"score":0.47955581545829773},{"id":"https://openalex.org/C148738053","wikidata":"https://www.wikidata.org/wiki/Q210861","display_name":"Cellular differentiation","level":3,"score":0.4709155261516571},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.46358466148376465},{"id":"https://openalex.org/C2779982571","wikidata":"https://www.wikidata.org/wiki/Q25098780","display_name":"Differentiation therapy","level":5,"score":0.4542428255081177},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.40921550989151},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.34788018465042114},{"id":"https://openalex.org/C149364088","wikidata":"https://www.wikidata.org/wiki/Q185917","display_name":"Translation (biology)","level":4,"score":0.3425670266151428},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.22565031051635742},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.17911189794540405},{"id":"https://openalex.org/C105580179","wikidata":"https://www.wikidata.org/wiki/Q188928","display_name":"Messenger RNA","level":3,"score":0.15925443172454834},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.12090712785720825},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.10434022545814514}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v104.11.886.886","doi":"https://doi.org/10.1182/blood.v104.11.886.886","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v104.11.886.886","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2552184685","https://openalex.org/W2552140255","https://openalex.org/W2077994180","https://openalex.org/W2748975134","https://openalex.org/W2558598364","https://openalex.org/W2007578289","https://openalex.org/W35929946","https://openalex.org/W2398984789","https://openalex.org/W2530371692","https://openalex.org/W2053585518"],"abstract_inverted_index":{"Abstract":[0],"All-trans-retinoic":[1],"acid":[2],"(ATRA)":[3],"induces":[4,128],"growth":[5,119,230],"inhibition,":[6],"differentiation":[7,25,198,234,352,409,426],"and":[8,24,45,73,84,97,139,199,208,232,249,254,262,268,353,371,403,428],"apoptosis":[9],"in":[10,31,64,69,86,121,136,173,193,228,278,292,300,311,321,336,350,366,411],"acute":[11,304],"promyelocytic":[12],"leukemia":[13,306,338],"(APL)":[14],"characterized":[15],"by":[16,212,235,266],"t(15;17),":[17],"which":[18,316],"leads":[19],"to":[20,51,60,382,393],"expression":[21,156,168,180,259,286,299,329,368,420],"of":[22,37,92,94,117,169,178,195,217,276,290,325,369,388,400,415,418],"PML-RARa":[23],"arrest.":[26],"ATRA":[27,52,72,83,127,154,246,295,301,322,401],"treatment":[28,277,291],"alone":[29],"results":[30],"complete":[32],"remission":[33],"(CR)":[34],"about":[35],"90%":[36],"APL":[38,46,75,122,174,384,412],"patients.":[39,76],"However":[40],"these":[41,95,389],"remissions":[42],"are":[43,357,364],"transient":[44],"patients":[47],"commonly":[48],"become":[49],"resistant":[50],"therapy.":[53],"Recently,":[54,108],"arsenic":[55],"trioxide,":[56],"As(2)O(3),":[57],"was":[58],"proven":[59],"be":[61],"highly":[62],"effective":[63],"inducing":[65],"CRs":[66],"not":[67,310],"only":[68],"relapsed":[70],"after":[71,273],"primary":[74],"Despite":[77],"the":[78,98,103,214,242,373,425],"well":[79],"documented":[80],"clinical":[81],"efficacy":[82],"As(2)O(3)":[85,250,281],"APL,":[87],"precise":[88],"downstream":[89],"molecular":[90,99,115],"mechanisms":[91,100,116,134],"action":[93,402],"agents":[96],"responsible":[101],"for":[102,189,241,424],"resistance":[104],"largely":[105],"remain":[106],"unknown.":[107],"employing":[109],"comprehensive":[110],"proteomics":[111],"methods":[112],"we":[113,221],"studied":[114],"ATRA-induced":[118,229,351,367,383,408],"inhibition":[120,231],"cells.":[123,175,280,339],"We":[124,150,239,356],"reported":[125],"that":[126,153,245,343,375,391],"translational":[129,237,344,378,394],"suppression":[130,379,395],"through":[131,332],"multiple":[132],"posttranscriptional":[133,416],"involved":[135,192,365],"translation":[137,157,170,207],"initiation":[138,158],"elongation":[140],"phases":[141],"(Harris":[142],"&Ozpolat":[143],"et":[144],"al,":[145],"Blood,":[146],"104":[147],"(5)":[148],"2004).":[149],"also":[151],"demonstrated":[152],"inhibits":[155,205],"factors":[159],"including":[160],"IF2,":[161],"eIF4AI,":[162],"eIF4G,":[163],"eIF5,":[164],"eIF6":[165],"but":[166,309],"upregulates":[167],"inhibitor":[171],"DAP5/p97/NAT1":[172],"Translational":[176],"control":[177,345,417],"gene":[179,190,419],"has":[181],"been":[182],"identified":[183],"as":[184],"an":[185],"important":[186],"regulatory":[187],"mechanism":[188,399],"products":[191],"regulation":[194],"cell":[196,202,385],"proliferation,":[197],"apoptosis.":[200],"Programmed":[201],"death":[203],"4(PDCD4)":[204],"cap-dependent":[206],"exerts":[209],"transformation-suppressing":[210],"activity":[211,216],"inhibiting":[213],"helicase":[215],"eIF4A.":[218],".":[219],"Here":[220],"investigated":[222],"whether":[223,360,376],"PDCD4":[224,258,284,297,328,370],"plays":[225],"a":[226,318,348,397],"role":[227,349],"terminal":[233],"mediating":[236],"suppression.":[238],"found":[240],"first":[243],"time":[244],"(1":[247],"mM)":[248,256],"(":[251],"0.4":[252],"mM":[253],"2":[255],"induced":[257,282,296],"at":[260,287],"mRNA":[261,298],"protein":[263,285],"level":[264],"detected":[265],"RT-PCR":[267],"western":[269],"blotting":[270],"analyses,":[271],"respectively,":[272],"24":[274],"h":[275,289],"NB4":[279,293],"maximum":[283],"72":[288],"cells":[294,307,314],"responsive":[302],"human":[303],"myeloid":[305],"(HL-60)":[308],"ATRA-resistant":[312],"HL60":[313],"(HL-60R),":[315],"express":[317],"point":[319],"mutation":[320],"binding":[323],"domain":[324],"RARa,":[326],"suggesting":[327],"is":[330,380],"mediated":[331],"retinoid":[333,362],"receptor":[334],"alpha":[335],"HL-60":[337],"Overall":[340],"data":[341],"suggest":[342],"may":[346,421],"play":[347],"As(2)O(3)-induced":[354],"effects.":[355],"currently":[358],"determining":[359],"other":[361],"receptors":[363],"testing":[372],"hypothesis":[374],"PDCD4-mediated":[377],"critical":[381],"differentiation.":[386],"Activation":[387],"pathways":[390],"lead":[392],"reveals":[396],"novel":[398,405],"provide":[404],"insights":[406],"into":[407],"program":[410],"cells.Better":[413],"understanding":[414],"offer":[422],"targets":[423],"therapy":[427],"chemo":[429],"preventive":[430],"strategies.":[431]},"counts_by_year":[{"year":2015,"cited_by_count":1}],"updated_date":"2026-09-21T07:43:02.447757","created_date":"2017-03-16T00:00:00"}